Chemokine decoy receptor D6 in inflammatory bowel disease (IBD) and IBD-associated colon cancer

被引：7
|
作者：
Collins, Colm B. [1 ]
McNamee, Eoin N. [1 ]
Wermers, Joshua D. [1 ]
Lebsack, Matthew D. P. [1 ]
Rivera-Nieves, Jesus [1 ]
机构：
[1] Univ Colorado, Hlth Sci Ctr, Div Gastroenterol, Dept Internal Med,Mucosal Inflammat Program, Aurora, CO 80045 USA
来源：
GUT | 2010年 / 59卷 / 02期
关键词：
SCAVENGER RECEPTOR;
D O I：
10.1136/gut.2009.192708
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：151 / 152
页数：4
相关论文
共 50 条
  • [1] Immune checkpoint markers in inflammatory bowel disease (IBD) and IBD-associated cancer
    Ephraim, Ramya
    Stavely, Rhian
    Fraser, Sarah
    Eri, Rajaraman
    Nurgali, Kulmira
    Apostolopoulos, Vasso
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2020, 32
  • [2] Association of inflammation related microRNA gene expression in inflammatory bowel disease and IBD-associated colon cancer
    Schetter, Aaron J.
    Welsh, Judith A.
    Bowman, Elise D.
    Harris, Curtis C.
    [J]. CANCER RESEARCH, 2011, 71
  • [3] ARC Is a Critical Protector against Inflammatory Bowel Disease (IBD) and IBD-Associated Colorectal Tumorigenesis
    Wang, Qiushi
    Zhang, Tianshun
    Chang, Xiaoyu
    Lim, Do Young
    Wang, Keke
    Bai, Ruihua
    Wang, Ting
    Ryu, Joohyun
    Chen, Hanyong
    Yao, Ke
    Ma, Wei-Ya
    Boardman, Lisa A.
    Bode, Ann M.
    Dong, Zigang
    [J]. CANCER RESEARCH, 2020, 80 (19) : 4158 - 4171
  • [4] Expression of the chemokine decoy receptor D6 is decreased in colon adenocarcinomas
    Langenes, Veronica
    Svensson, Helena
    Borjesson, Lars
    Gustavsson, Bengt
    Bemark, Mats
    Sjoling, Asa
    Quiding-Jarbrink, Marianne
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2013, 62 (11) : 1687 - 1695
  • [5] Expression of the chemokine decoy receptor D6 is decreased in colon adenocarcinomas
    Veronica Langenes
    Helena Svensson
    Lars Börjesson
    Bengt Gustavsson
    Mats Bemark
    Åsa Sjöling
    Marianne Quiding-Järbrink
    [J]. Cancer Immunology, Immunotherapy, 2013, 62 : 1687 - 1695
  • [6] Inflammatory bowel disease - exome sequencing in IBD and colon cancer
    Pommer, Peter
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2016, 54 (06): : 534 - 534
  • [7] The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6
    Vetrano, Stefania
    Borroni, Elena M.
    Sarukhan, Adelaida
    Savino, Benedetta
    Bonecchi, Raffaella
    Correale, Carmen
    Arena, Vincenzo
    Fantini, Massimo
    Roncalli, Massimo
    Malesci, Alberto
    Mantovani, Alberto
    Locati, Massimo
    Danese, Silvio
    [J]. GUT, 2010, 59 (02) : 197 - 206
  • [8] The CC chemokine receptor 5 Δ32 mutation is not associated with inflammatory bowel disease (IBD) in NE England
    A Craggs
    M Welfare
    PT Donaldson
    JC Mansfield
    [J]. Genes & Immunity, 2001, 2 : 114 - 116
  • [9] The CC chemokine receptor 5 Δ32 mutation is not associated with inflammatory bowel disease (IBD) in NE England
    Craggs, A
    Welfare, M
    Donaldson, PT
    Mansfield, JC
    [J]. GENES AND IMMUNITY, 2001, 2 (02) : 114 - 116
  • [10] The Lymphatic System Controls Intestinal Inflammation and Inflammation-Associated Colon Cancer Through the Chemokine Decoy Receptor D6
    Vetrano, Stefania
    Borroni, Elena M.
    Bonecchi, Raffaella
    Correale, Carmen
    Sarukhan, Adelaida
    Arena, Vincenzo
    Fantini, Massimo C.
    Roncalli, Massimo
    Malesci, Alberto
    Vecchi, Annunciata
    Mantovani, Alberto
    Locati, Massimo
    Danese, Silvio
    [J]. GASTROENTEROLOGY, 2009, 136 (05) : A59 - A59
12345